Radiomic profiling indicates that both tumor laterality and patient age influence the relationship between imaging features and clinical outcomes in NF2-associated VS. Homogeneity was linked to aggressive growth in younger patients, heterogeneity characterized progression in older patients. These findings suggest that radiomic biomarkers may complement volumetric measures and support individualized monitoring and treatment strategies in NF2.
Boe et al. (2026) studied this question.